Potential conflict of interest: The antimurine MCP-1 inhibitor, mNOX-E36, was kindly provided by NOXXON Pharma AG. D.E. is an employee of NOXXON Pharma AG (Berlin, Germany).
Liver Failure/Cirrhosis/Portal Hypertension
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
Article first published online: 30 JAN 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 3, pages 1060–1072, March 2014
How to Cite
Baeck, C., Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C. and Tacke, F. (2014), Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice. Hepatology, 59: 1060–1072. doi: 10.1002/hep.26783
This work was supported by the German Research Foundation (DFG Ta434/2-1 and DFG SFB/TRR 57) and by the Interdisciplinary Center for Clinical Research (IZKF), Aachen, Germany.
- Issue published online: 25 FEB 2014
- Article first published online: 30 JAN 2014
- Accepted manuscript online: 8 OCT 2013 02:55PM EST
- Manuscript Accepted: 1 OCT 2013
- Manuscript Received: 5 APR 2013
Additional Supporting Information may be found in the online version of this article.
|hep26783-sup-0001-suppfigs.pdf||596K||Supplementary Information Figures|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.